Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $20.2900 (1.6%) ($19.9600 - $20.5200) on Tue. Feb. 12, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.64% (three month average) | RSI | 54 | Latest Price | $20.2900(1.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.8% a day on average for past five trading days. | Weekly Trend | EDIT declines -1.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(64%) ARKG(61%) XBI(60%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.82% in a week (0% probabilities). VXX(-12%) VIXM(-8%) XHB(-4%) TLT(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.82% (StdDev 5.64%) | Hourly BBV | 0 () | Intraday Trend | 0.9% | | | |
|
1 - 5 Day Possible Target | $0.94(-95.37%) | Resistance Level | $21.79 | 5 Day Moving Average | $20.11(0.9%) | 10 Day Moving Average | $20.78(-2.36%) | 20 Day Moving Average | $21.79(-6.88%) | To recent high | -36.2% | To recent low | 11.5% | Market Cap | $1.26b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |